Literature DB >> 28209611

Genetic Manipulation of Helicobacter pylori Virulence Function by Host Carcinogenic Phenotypes.

Giovanni Suarez1, Judith Romero-Gallo1, Johanna C Sierra1, M Blanca Piazuelo1, Uma S Krishna1, Martin A Gomez2,3, Keith T Wilson1, Richard M Peek4.   

Abstract

Helicobacter pylori is the strongest risk factor for gastric adenocarcinoma, yet only a minority of infected persons ever develop this malignancy. One cancer-linked locus is the cag type 4 secretion system (cagT4SS), which translocates an oncoprotein into host cells. A structural component of the cagT4SS is CagY, which becomes rapidly altered during in vivo adaptation in mice and rhesus monkeys, rendering the cagT4SS nonfunctional; however, these models rarely develop gastric cancer. We previously demonstrated that the H. pylori cag+ strain 7.13 rapidly induces gastric cancer in Mongolian gerbils. We now use this model, in conjunction with samples from patients with premalignant lesions, to define the effects of a carcinogenic host environment on the virulence phenotype of H. pylori to understand how only a subset of infected individuals develop cancer. H. pylori cagY sequence differences and cagT4SS function were directly related to the severity of inflammation in human gastric mucosa in either a synchronous or metachronous manner. Serial infections of Mongolian gerbils with H. pylori strain 7.13 identified an oscillating pattern of cagT4SS function. The development of dysplasia or cancer selected for attenuated virulence phenotypes, but robust cagT4SS function could be restored upon infection of new hosts. Changes in the genetic composition of cagY mirrored cagT4SS function, although the mechanisms of cagY alterations differed in human isolates (mutations) versus gerbil isolates (addition/deletion of motifs). These results indicate that host carcinogenic phenotypes modify cagT4SS function via altering cagY, allowing the bacteria to persist and induce carcinogenic consequences in the gastric niche. Cancer Res; 77(9); 2401-12. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28209611      PMCID: PMC5413443          DOI: 10.1158/0008-5472.CAN-16-2922

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

Review 1.  Immune evasion strategies used by Helicobacter pylori.

Authors:  Taslima T Lina; Shatha Alzahrani; Jazmin Gonzalez; Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Modification of Helicobacter pylori Peptidoglycan Enhances NOD1 Activation and Promotes Cancer of the Stomach.

Authors:  Giovanni Suarez; Judith Romero-Gallo; M Blanca Piazuelo; Ge Wang; Robert J Maier; Lennart S Forsberg; Parastoo Azadi; Martin A Gomez; Pelayo Correa; Richard M Peek
Journal:  Cancer Res       Date:  2015-03-02       Impact factor: 12.701

3.  Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island.

Authors:  Jérôme Viala; Catherine Chaput; Ivo G Boneca; Ana Cardona; Stephen E Girardin; Anthony P Moran; Rafika Athman; Sylvie Mémet; Michel R Huerre; Anthony J Coyle; Peter S DiStefano; Philippe J Sansonetti; Agnès Labigne; John Bertin; Dana J Philpott; Richard L Ferrero
Journal:  Nat Immunol       Date:  2004-10-17       Impact factor: 25.606

4.  Oxidative stress-induced peptidoglycan deacetylase in Helicobacter pylori.

Authors:  Ge Wang; Adriana Olczak; Lennart S Forsberg; Robert J Maier
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

5.  Genetic Evolution of a Helicobacter pylori Acid-Sensing Histidine Kinase and Gastric Disease.

Authors:  Uma Krishna; Judith Romero-Gallo; Giovanni Suarez; Ayeetin Azah; Andrzej M Krezel; Matthew G Varga; Mark H Forsyth; Richard M Peek
Journal:  J Infect Dis       Date:  2016-05-10       Impact factor: 5.226

6.  Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506).

Authors:  T Ogawa; Y Suda; W Kashihara; T Hayashi; T Shimoyama; S Kusumoto; T Tamura
Journal:  Vaccine       Date:  1997-10       Impact factor: 3.641

7.  CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions.

Authors:  L A Sicinschi; P Correa; R M Peek; M C Camargo; M B Piazuelo; J Romero-Gallo; S S Hobbs; U Krishna; A Delgado; R Mera; L E Bravo; B G Schneider
Journal:  Clin Microbiol Infect       Date:  2009-05-15       Impact factor: 8.067

8.  Development of gastric adenocarcinoma in Mongolian gerbils after long-term infection with Helicobacter pylori.

Authors:  Qing Zheng; Xiao Yu Chen; Yao Shi; Shu Dong Xiao
Journal:  J Gastroenterol Hepatol       Date:  2004-10       Impact factor: 4.029

9.  Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil.

Authors:  K Ogura; S Maeda; M Nakao; T Watanabe; M Tada; T Kyutoku; H Yoshida; Y Shiratori; M Omata
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

10.  Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system.

Authors:  M G Varga; C L Shaffer; J C Sierra; G Suarez; M B Piazuelo; M E Whitaker; J Romero-Gallo; U S Krishna; A Delgado; M A Gomez; J A D Good; F Almqvist; E P Skaar; P Correa; K T Wilson; M Hadjifrangiskou; R M Peek
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

View more
  9 in total

1.  α-Difluoromethylornithine reduces gastric carcinogenesis by causing mutations in Helicobacter pylori cagY.

Authors:  Johanna C Sierra; Giovanni Suarez; M Blanca Piazuelo; Paula B Luis; Dara R Baker; Judith Romero-Gallo; Daniel P Barry; Claus Schneider; Douglas R Morgan; Richard M Peek; Alain P Gobert; Keith T Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-25       Impact factor: 11.205

2.  Nod1 Imprints Inflammatory and Carcinogenic Responses toward the Gastric Pathogen Helicobacter pylori.

Authors:  Giovanni Suarez; Judith Romero-Gallo; Maria B Piazuelo; Johanna C Sierra; Alberto G Delgado; M Kay Washington; Shailja C Shah; Keith T Wilson; Richard M Peek
Journal:  Cancer Res       Date:  2019-01-29       Impact factor: 12.701

3.  Helicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apoptosis.

Authors:  Manikandan Palrasu; Elena Zaika; Kodisundaram Paulrasu; Ravindran Caspa Gokulan; Giovanni Suarez; Jianwen Que; Wael El-Rifai; Richard M Peek; Monica Garcia-Buitrago; Alexander I Zaika
Journal:  PLoS Pathog       Date:  2022-06-29       Impact factor: 7.464

4.  Temporal Control of the Helicobacter pylori Cag Type IV Secretion System in a Mongolian Gerbil Model of Gastric Carcinogenesis.

Authors:  Aung Soe Lin; Mark S McClain; Amber C Beckett; Rhonda R Caston; M Lorena Harvey; Beverly R E A Dixon; Anne M Campbell; Jennifer H B Shuman; Neha Sawhney; Alberto G Delgado; John T Loh; M Blanca Piazuelo; Holly M Scott Algood; Timothy L Cover
Journal:  mBio       Date:  2020-06-30       Impact factor: 7.867

Review 5.  Pathogenesis and clinical management of Helicobacter pylori gastric infection.

Authors:  Breno Bittencourt de Brito; Filipe Antônio França da Silva; Aline Silva Soares; Vinícius Afonso Pereira; Maria Luísa Cordeiro Santos; Mariana Miranda Sampaio; Pedro Henrique Moreira Neves; Fabrício Freire de Melo
Journal:  World J Gastroenterol       Date:  2019-10-07       Impact factor: 5.742

6.  Host immune response mediates changes in cagA copy number and virulence potential of Helicobacter pylori.

Authors:  Sungil Jang; Lori M Hansen; Hanfu Su; Jay V Solnick; Jeong-Heon Cha
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 7.  Inflammation and Gastric Cancer.

Authors:  Aunchalee Jaroenlapnopparat; Khushboo Bhatia; Sahin Coban
Journal:  Diseases       Date:  2022-06-22

8.  ptk2 and mt2a Genes Expression in Gastritis and Gastric Cancer Patients with Helicobacter pylori Infection.

Authors:  Manouchehr Ahmadi Hedayati; Delniya Khani; Farshad Sheikhesmaeili; Bijan Nouri
Journal:  Can J Gastroenterol Hepatol       Date:  2022-08-25

Review 9.  Helicobacter pylori Virulence Factor Cytotoxin-Associated Gene A (CagA)-Mediated Gastric Pathogenicity.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.